Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Transsternal Versus Transcervical Thymectomy [NA]
A completed clinical trial comparing transsternal and transcervical thymectomy approaches for myasthenia gravis has finished.
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis [Phase 1, Phase 2]
The document reports on the safety, tolerability, and immunogenic response of the investigational CV-MG01 in patients with Myasthenia gravis…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: BeatMG: Phase II Trial of Rituximab In Myasthenia Gravis [Phase 2]
Phase II trial of rituximab in myasthenia gravis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia Gravis [Phase 1]
Phase 1 trial update evaluating hematopoietic stem cell therapy for patients with refractory myasthenia gravis; study terminated with result…
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Variables Predicting Reintubation After Thymectomy in Patients With Myasthenia Gravis
This clinical trial update examines factors that predict the need for reintubation after thymectomy in patients with Myasthenia Gravis. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-20FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Method Pharmaceuticals, LLC)
The FDA approved an original application for pyridostigmine bromide by Method Pharmaceuticals LLC, adding a generic version of the cholinest…
-
FDA approval · 2018-07-10FDA Approved: NEOSTIGMINE — Original Application (Dr.Reddy's Laboratories Inc)
FDA approved Dr. Reddy's Laboratories' original application for neostigmine, a generic acetylcholinesterase inhibitor used to treat myasthen…
-
FDA approval · 2018-06-15FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Amneal Pharmaceuticals LLC)
FDA approval of a generic neostigmine methylsulfate product (ANDA) by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: A Study to Evaluate the Efficacy of CV-MG01 (Myasterix) in Myasthenia Gravis [Phase 2, Phase 3]
The CV-MG01 (Myasterix) trial for generalized myasthenia gravis has been withdrawn from Phase 2/Phase 3 development.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis [Phase 4]
A Phase 4 clinical trial evaluating the effect of pyridostigmine (Mestinon) on muscle strength in patients with Myasthenia Gravis.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis [Phase 4]
This Phase 4 clinical trial compared two prednisone tapering strategies in myasthenia gravis and has completed. The study status is COMPLETE…
-
FDA approval · 2017-09-25FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Amphastar Pharmaceuticals, Inc.)
FDA approved Amphastar Pharmaceuticals' neostigmine methylsulfate as an original ANDA (ANDA209933) for indications including treatment of my…
-
FDA approval · 2017-08-15FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approves a generic pyridostigmine bromide product under an Original Application (ANDA205464). The indication is treatment of myasthenia …
-
FDA approval · 2017-04-26FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Par Health USA, LLC)
FDA approved Par Health USA, LLC's original application for a generic neostigmine methylsulfate product. This marks the availability of a ge…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy [Phase 3]
A Phase 3 trial evaluated thymectomy in non-thymomatous myasthenia gravis patients receiving prednisone, and the results have been posted af…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis [Phase 2]
Phase 2 trial investigating safety and efficacy of eculizumab in patients with refractory generalized myasthenia gravis was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Exercise for Stable Myasthenia Gravis [Phase 1]
This entry describes a Phase 1 clinical trial evaluating exercise for individuals with stable myasthenia gravis, with the trial status curre…
-
FDA approval · 2016-05-18FDA Approved: REGONOL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Regonol (pyridostigmine bromide) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: The Evaluation of Belimumab in Myasthenia Gravis (MG) [Phase 2]
Phase 2 clinical trial evaluating belimumab for myasthenia gravis has completed, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis [Phase 3]
Phase 3 clinical trial evaluating tacrolimus capsules for efficacy and safety in Myasthenia Gravis has completed.
-
FDA approval · 2015-12-28FDA Approved: NEOSTIGMINE METHYLSULFATE — Original Application (Civica, Inc.)
FDA approved Civica, Inc.'s original application for Neostigmine Methylsulfate, a generic version of the drug.
-
FDA approval · 2015-12-23FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Surgeon General-Department of the Army (TSG-DA))
FDA approved a supplemental application for pyridostigmine bromide submitted by the Surgeon General, Department of the Army.
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Efficacy of Methotrexate in Myasthenia Gravis [Phase 2]
Phase 2 trial evaluating the efficacy of methotrexate in myasthenia gravis has been completed and results have been posted.
-
FDA approval · 2015-10-20FDA Approved: BLOXIVERZ — Supplemental Application (Exela Pharma Sciences, LLC)
The FDA approved a supplemental application for BLOXIVERZ (neostigmine methylsulfate) submitted by Exela Pharma Sciences, LLC.
-
CLINICAL_TRIALS research · 2015-07-16Clinical Trial Update: Therapeutic Plasma Exchange in MG
A completed Duke University-sponsored clinical trial evaluating therapeutic plasma exchange for Myasthenia Gravis.